Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

CD117hi expression identifies a human fetal Hematopoietic Stem Cell population with high proliferation and self-renewal potential.

Maillard L, Sanfilippo S, Domenech C, Kasmi N, Petit L, Jacques S, Delezoide AL, Guimiot F, Eladak S, Moison D, Nicolas N, Rouiller-Fabre V, Pozzi-Godin S, Mennesson B, Brival ML, Letourneur F, Jaffredo T, Chomienne C, Souyri M.

Haematologica. 2019 Jun 27. pii: haematol.2018.207811. doi: 10.3324/haematol.2018.207811. [Epub ahead of print]

2.

Studies in an Early Development Window Unveils a Severe HSC Defect in both Murine and Human Fanconi Anemia.

Domenech C, Maillard L, Rousseau A, Guidez F, Petit L, Pla M, Clay D, Guimiot F, Sanfilippo S, Jacques S, de la Grange P, Robil N, Soulier J, Souyri M.

Stem Cell Reports. 2018 Nov 13;11(5):1075-1091. doi: 10.1016/j.stemcr.2018.10.001. Epub 2018 Oct 25.

3.

Endothelial autophagic flux hampers atherosclerotic lesion development.

Kheloufi M, Vion AC, Hammoutene A, Poisson J, Lasselin J, Devue C, Pic I, Dupont N, Busse J, Stark K, Lafaurie-Janvore J, Barakat AI, Loyer X, Souyri M, Viollet B, Julia P, Tedgui A, Codogno P, Boulanger CM, Rautou PE.

Autophagy. 2018;14(1):173-175. doi: 10.1080/15548627.2017.1395114. Epub 2018 Jan 29.

4.

Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow.

Vion AC, Kheloufi M, Hammoutene A, Poisson J, Lasselin J, Devue C, Pic I, Dupont N, Busse J, Stark K, Lafaurie-Janvore J, Barakat AI, Loyer X, Souyri M, Viollet B, Julia P, Tedgui A, Codogno P, Boulanger CM, Rautou PE.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8675-E8684. doi: 10.1073/pnas.1702223114. Epub 2017 Sep 25.

5.

Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.

Luque Y, Lenoir O, Bonnin P, Hardy L, Chipont A, Placier S, Vandermeersch S, Xu-Dubois YC, Robin B, Lazareth H, Souyri M, Guyonnet L, Baudrie V, Camerer E, Rondeau E, Mesnard L, Tharaux PL.

J Am Soc Nephrol. 2017 Dec;28(12):3563-3578. doi: 10.1681/ASN.2016090960. Epub 2017 Sep 19.

6.

Monoclonal antibody 1.6.1 against human MPL receptor allows HSC enrichment of CB and BM CD34(+)CD38(-) populations.

Petit Cocault L, Fleury M, Clay D, Larghero J, Vanneaux V, Souyri M.

Exp Hematol. 2016 Apr;44(4):297-302.e1. doi: 10.1016/j.exphem.2015.12.004. Epub 2015 Dec 28.

PMID:
26733047
7.

Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.

Lenoir O, Jasiek M, Hénique C, Guyonnet L, Hartleben B, Bork T, Chipont A, Flosseau K, Bensaada I, Schmitt A, Massé JM, Souyri M, Huber TB, Tharaux PL.

Autophagy. 2015;11(7):1130-45. doi: 10.1080/15548627.2015.1049799.

8.

[Tissue to tissue dialogue and modulation of the Notch pathway control aortic haematopoiesis].

Drevon C, Richard C, Lempereur A, Canto PY, Souyri M, Jaffredo T.

Med Sci (Paris). 2013 Nov;29(11):946-8. doi: 10.1051/medsci/20132911005. Epub 2013 Nov 20. French. No abstract available.

9.

Dorso-ventral contributions in the formation of the embryonic aorta and the control of aortic hematopoiesis.

Jaffredo T, Lempereur A, Richard C, Bollerot K, Gautier R, Canto PY, Drevon C, Souyri M, Durand C.

Blood Cells Mol Dis. 2013 Dec;51(4):232-8. doi: 10.1016/j.bcmd.2013.07.004. Epub 2013 Aug 7. Review.

PMID:
23932235
10.

Endothelio-mesenchymal interaction controls runx1 expression and modulates the notch pathway to initiate aortic hematopoiesis.

Richard C, Drevon C, Canto PY, Villain G, Bollérot K, Lempereur A, Teillet MA, Vincent C, Rosselló Castillo C, Torres M, Piwarzyk E, Speck NA, Souyri M, Jaffredo T.

Dev Cell. 2013 Mar 25;24(6):600-11. doi: 10.1016/j.devcel.2013.02.011.

11.

Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage.

de Laval B, Pawlikowska P, Petit-Cocault L, Bilhou-Nabera C, Aubin-Houzelstein G, Souyri M, Pouzoulet F, Gaudry M, Porteu F.

Cell Stem Cell. 2013 Jan 3;12(1):37-48. doi: 10.1016/j.stem.2012.10.012. Epub 2012 Dec 13.

12.

Concomitant multipotent and unipotent dental pulp progenitors and their respective contribution to mineralised tissue formation.

Lacerda-Pinheiro S, Dimitrova-Nakov S, Harichane Y, Souyri M, Petit-Cocault L, Legrès L, Marchadier A, Baudry A, Ribes S, Goldberg M, Kellermann O, Poliard A.

Eur Cell Mater. 2012 May 24;23:371-86.

13.

Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta.

Roques M, Durand C, Gautier R, Canto PY, Petit-Cocault L, Yvernogeau L, Dunon D, Souyri M, Jaffredo T.

Haematologica. 2012 Jul;97(7):975-9. doi: 10.3324/haematol.2011.046235. Epub 2012 Jan 22.

14.

Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression.

Oberlin E, El Hafny B, Petit-Cocault L, Souyri M.

Int J Dev Biol. 2010;54(6-7):1165-73. doi: 10.1387/ijdb.103121eo.

15.
16.

VE-cadherin expression allows identification of a new class of hematopoietic stem cells within human embryonic liver.

Oberlin E, Fleury M, Clay D, Petit-Cocault L, Candelier JJ, Mennesson B, Jaffredo T, Souyri M.

Blood. 2010 Nov 25;116(22):4444-55. doi: 10.1182/blood-2010-03-272625. Epub 2010 Aug 6.

17.

The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis.

Guihard S, Clay D, Cocault L, Saulnier N, Opolon P, Souyri M, Pagès G, Pouysségur J, Porteu F, Gaudry M.

Blood. 2010 May 6;115(18):3686-94. doi: 10.1182/blood-2009-09-242487. Epub 2010 Mar 11.

18.

Dual role of Mpl receptor during the establishment of definitive hematopoiesis.

Petit-Cocault L, Volle-Challier C, Fleury M, Péault B, Souyri M.

Development. 2007 Aug;134(16):3031-40. Epub 2007 Jul 18.

19.

The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells.

Challier C, Cocault L, Berthier R, Binart N, Dusanter-Fourt I, Uzan G, Souyri M.

Blood. 2002 Sep 15;100(6):2063-70.

20.

Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response.

Levin J, Cocault L, Demerens C, Challier C, Pauchard M, Caen J, Souyri M.

Blood. 2001 Aug 15;98(4):1019-27.

21.

A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.

Challier C, Cocault L, Flon M, Pauchard M, Porteu F, Gisselbrecht S, Souyri M.

Oncogene. 2000 Apr 13;19(16):2033-42.

22.
23.
24.

Ectopic expression of murine TPO receptor (c-mpl) in mice is pathogenic and induces erythroblastic proliferation.

Cocault L, Bouscary D, Le Bousse Kerdiles C, Clay D, Picard F, Gisselbrecht S, Souyri M.

Blood. 1996 Sep 1;88(5):1656-65.

25.

Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.

Porteu F, Rouyez MC, Cocault L, Bénit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I.

Mol Cell Biol. 1996 May;16(5):2473-82.

26.

Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I.

EMBO J. 1995 Jun 15;14(12):2847-56.

27.

Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.

Vigon I, Florindo C, Fichelson S, Guenet JL, Mattei MG, Souyri M, Cosman D, Gisselbrecht S.

Oncogene. 1993 Oct;8(10):2607-15.

PMID:
8397366
28.

Expression of the c-mpl proto-oncogene in human hematologic malignancies.

Vigon I, Dreyfus F, Melle J, Viguié F, Ribrag V, Cocault L, Souyri M, Gisselbrecht S.

Blood. 1993 Aug 1;82(3):877-83.

29.

Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.

Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M.

Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5640-4.

30.

Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome.

Le Bousse-Kerdilès MC, Souyri M, Smadja-Joffe F, Praloran V, Jasmin C, Ziltener HJ.

Blood. 1992 Jun 15;79(12):3179-87.

31.

Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.

Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffé M, Berger R, Larsen CJ, Mathieu-Mahul D.

Oncogene. 1991 Aug;6(8):1477-88.

PMID:
1886719
32.

A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors.

Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F.

Cell. 1990 Dec 21;63(6):1137-47.

PMID:
2175677
33.

The human homolog of the myeloproliferative virus maps to chromosome band 1p34.

Le Coniat M, Souyri M, Vigon I, Wendling F, Tambourin P, Berger R.

Hum Genet. 1989 Sep;83(2):194-6.

PMID:
2550356
34.

Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Souyri M, Vigon I, Charon M, Tambourin P.

J Virol. 1989 Sep;63(9):3944-53.

36.

Biological effects of a murine retrovirus carrying an activated N-ras gene of human origin.

Souyri M, Koehne CF, O'Donnell PV, Aldrich TH, Furth ME, Fleissner E.

Virology. 1987 May;158(1):69-78.

PMID:
3576974
37.

Identification by transfection of transforming sequences in DNA of human T-cell leukemias.

Souyri M, Fleissner E.

Proc Natl Acad Sci U S A. 1983 Nov;80(21):6676-9.

38.

Evidence for a new form of retroviral env transcript in leukemic and normal mouse lymphoid cells.

Boccara M, Souyri M, Magarian C, Stavnezer E, Fleissner E.

J Virol. 1983 Oct;48(1):102-9.

Supplemental Content

Loading ...
Support Center